Jian Ma

8.8k total citations · 2 hit papers
126 papers, 6.1k citations indexed

About

Jian Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jian Ma has authored 126 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 42 papers in Cancer Research and 41 papers in Oncology. Recurrent topics in Jian Ma's work include RNA modifications and cancer (29 papers), Cancer-related molecular mechanisms research (24 papers) and Viral-associated cancers and disorders (17 papers). Jian Ma is often cited by papers focused on RNA modifications and cancer (29 papers), Cancer-related molecular mechanisms research (24 papers) and Viral-associated cancers and disorders (17 papers). Jian Ma collaborates with scholars based in China, United States and Saudi Arabia. Jian Ma's co-authors include Guiyuan Li, Siwen Wang, Ziyi Wang, Shaoxiong Wang, Wei Xiong, Rui Song, Xiaoling Li, Bo Xiang, Zhaoyang Zeng and Xiayu Li and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Jian Ma

117 papers receiving 6.1k citations

Hit Papers

Role of the tumor microenvironment in PD-L1/PD-1-mediated... 2018 2026 2020 2023 2019 2018 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
    2019 1.1k citations Bo Xiang, Xu Wu et al. Molecular Cancer profile →
  2. S100A8/A9 in Inflammation
    2018 928 citations Siwen Wang, Rui Song et al. Frontiers in Immunology profile →

Peers

Jian Ma
Jochen Heß Germany
Elvira Pelosi Italy
Filip Lardon Belgium
Elaine M. Hurt United States
Maria Li Lung Hong Kong
Yiwei Chu China
Catherine O′Brien Canada
Pei‐Yi Chu Taiwan
Carter Van Waes United States
Mengfeng Li China
Jochen Heß Germany
Jian Ma
Citations per year, relative to Jian Ma Jian Ma (= 1×) peers Jochen Heß

Countries citing papers authored by Jian Ma

Since Specialization
Citations

This map shows the geographic impact of Jian Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Ma more than expected).

Fields of papers citing papers by Jian Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Ma. The network helps show where Jian Ma may publish in the future.

Co-authorship network of co-authors of Jian Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Ma. A scholar is included among the top collaborators of Jian Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Ma. Jian Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Zhengyu, Wenchao Li, Lingyu Wei, & Jian Ma. (2025). Lactoferrin in cancer: Focus on mechanisms and translational medicine. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(3). 189330–189330. 2 indexed citations
2.
Li, Xiangling, et al.. (2025). Exogenous Extracellular Vesicles as Emerging Platforms in Translational Medicine. SHILAP Revista de lepidopterología. 6(1). 3 indexed citations
3.
Ai, Feiyan, Xing Wu, Wentao Yu, et al.. (2024). Analysis of neutrophil extracellular trap‐related genes in Crohn's disease based on bioinformatics. Journal of Cellular and Molecular Medicine. 28(16). e70013–e70013. 3 indexed citations
4.
Huang, Jin, Guofeng Zhao, Peng Qiu, et al.. (2023). Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T‐cell receptor sequencing. Molecular Oncology. 17(8). 1531–1544. 2 indexed citations
5.
Zhang, Xiaoyue, Can Liu, Zhengshuo Li, et al.. (2023). Epstein–Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1. Journal of Biological Chemistry. 299(9). 105082–105082. 5 indexed citations
6.
Zhang, Xiaoyue, Run Zheng, Zhengshuo Li, & Jian Ma. (2023). Liquid-liquid Phase Separation in Viral Function. Journal of Molecular Biology. 435(16). 167955–167955. 22 indexed citations
7.
Luo, Jiadi, Ying Zhou, Hongjing Zang, et al.. (2022). Overexpressed p-S6 associates with lymph node metastasis and predicts poor prognosis in non-small cell lung cancer. BMC Cancer. 22(1). 564–564. 5 indexed citations
8.
Gao, Yingxue, et al.. (2021). EBV as a high infection risk factor promotes RASSF10 methylation and induces cell proliferation in EBV-associated gastric cancer. Biochemical and Biophysical Research Communications. 547. 1–8. 7 indexed citations
9.
Liu, Kun, et al.. (2020). Long Noncoding RNA HIF1A-AS2 Promotes Non-Small Cell Lung Cancer Progression by the miR-153-5p/S100A14 Axis. SHILAP Revista de lepidopterología. 1 indexed citations
10.
He, Xu, Jian Ma, Jun Zhang, Jingang Cui, & Hao Yang. (2020). Long Non-Coding RNA SNHG16 Activates USP22 Expression to Promote Colorectal Cancer Progression by Sponging miR-132-3p. SHILAP Revista de lepidopterología.
11.
Li, Zhengshuo, Jing Wang, Xuemei Zhang, et al.. (2020). Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape. The Journal of Immunology. 204(9). 2589–2599. 34 indexed citations
12.
Wang, Yian, Xiaoling Li, Yongzhen Mo, et al.. (2018). Effects of tumor metabolic microenvironment on regulatory T cells. Molecular Cancer. 17(1). 143 indexed citations
13.
Wang, Siwen, et al.. (2018). S100A8/A9 in Inflammation. Frontiers in Immunology. 9. 1298–1298. 928 indexed citations breakdown →
14.
Zhao, Ran, Yukun Liu, Heran Wang, et al.. (2016). BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway. Cellular and Molecular Immunology. 14(10). 830–841. 41 indexed citations
15.
Zheng, Ying, Wenling Zhang, Qiurong Ye, et al.. (2012). Inhibition of Epstein-Barr Virus Infection by Lactoferrin. Journal of Innate Immunity. 4(4). 387–398. 33 indexed citations
16.
Zeng, Zhaoyang, Hongbin Huang, Bo Xiang, et al.. (2011). Nasopharyngeal carcinoma: Advances in genomics and molecular genetics. Science China Life Sciences. 54(10). 966–975. 53 indexed citations
17.
Zhou, Yanhong, Wei Wang, Shuping Peng, et al.. (2011). Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes. Medical Oncology. 29(3). 1456–1462. 17 indexed citations
18.
Wang, Lili, Qiuhong Zhang, Jian Ma, et al.. (2005). Role of NGX6 in nasopharyngeal carcinoma with high ability of metastasis cell line 5--8F. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 32(7). 618–624. 1 indexed citations
19.
Shao, Chen, et al.. (2003). Angiogenic Inhibitor Plasminogen Kringle 5 Down-Regulates the Expression of Vascular Endothelial Growth Factor in Müller Cells. Investigative Ophthalmology & Visual Science. 44(13). 2879–2879. 2 indexed citations
20.
Ma, Jian, Jiang Li, Jie Zhou, et al.. (2002). Profiling genes differentially expressed in NGX6 overexpressed nasopharyngeal carcinoma cells by cDNA array. Journal of Cancer Research and Clinical Oncology. 128(12). 683–690. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Heß Breakdown of academic impact, for papers by Elvira Pelosi Breakdown of academic impact, for papers by Filip Lardon Breakdown of academic impact, for papers by Elaine M. Hurt Breakdown of academic impact, for papers by Maria Li Lung Breakdown of academic impact, for papers by Yiwei Chu Breakdown of academic impact, for papers by Catherine O′Brien Breakdown of academic impact, for papers by Pei‐Yi Chu Breakdown of academic impact, for papers by Carter Van Waes Breakdown of academic impact, for papers by Mengfeng Li
Rankless by CCL
2026